Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
Acq. announced
CC transcript
|
|
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/05/2023 |
4
| BAKER BROS. ADVISORS LP (Director) has filed a Form 4 on MADRIGAL PHARMACEUTICALS, INC.|
Txns:
| Bought 125,447 warrants
@ $0.0001, valued at
$12.5
Bought 1,522,651 warrants
@ $0.0001, valued at
$152.3 |
|
| 03/02/2023 |
4
| Waltermire Robert E. (Senior VP, Chief Pharma Dev.) has filed a Form 4 on MADRIGAL PHARMACEUTICALS, INC.|
Txns:
| Sold 900 shares
@ $271.03, valued at
$243.9k
Sold 4,100 shares
@ $272.3, valued at
$1.1M
Sold 1,928 shares
@ $273.44, valued at
$527.2k
Sold 1,672 shares
@ $274.57, valued at
$459.1k
Sold 1,300 shares
@ $275.53, valued at
$358.2k
Sold 100 shares
@ $276.19, valued at
$27.6k
Exercised 5,000 options to buy
@ $87.92, valued at
$439.6k
Exercised 5,000 options to buy
@ $87.92, valued at
$439.6k
|
|
| 01/19/2023 |
4
| Levy Richard S (Director) has filed a Form 4 on MADRIGAL PHARMACEUTICALS, INC.|
Txns:
| Sold 100 shares
@ $285.28, valued at
$28.5k
Sold 400 shares
@ $287.08, valued at
$114.8k
Sold 300 shares
@ $288.91, valued at
$86.7k
Sold 1,600 shares
@ $290.36, valued at
$464.6k
Sold 3,325 shares
@ $291.66, valued at
$969.8k
Sold 5,227 shares
@ $292.68, valued at
$1.5M
Sold 3,548 shares
@ $293.54, valued at
$1M
Sold 5,164 shares
@ $294.68, valued at
$1.5M
Sold 2,325 shares
@ $295.45, valued at
$686.9k
Sold 500 shares
@ $296.68, valued at
$148.3k
Exercised 12,489 options to buy
@ $105.08, valued at
$1.3M
|
|
| 01/18/2023 |
4
| Sukhija Remy (Chief Commercial Officer) has filed a Form 4 on MADRIGAL PHARMACEUTICALS, INC.|
Txns:
| Granted 15,001 shares
@ $0 |
|
| 01/18/2023 |
4
| Waltermire Robert E. (Senior VP, Chief Pharma Dev.) has filed a Form 4 on MADRIGAL PHARMACEUTICALS, INC.|
Txns:
| Granted 5,667 shares
@ $0 |
|
| 01/18/2023 |
4
| Lynch Brian Joseph (SVP and General Counsel) has filed a Form 4 on MADRIGAL PHARMACEUTICALS, INC.|
Txns:
| Granted 15,001 shares
@ $0 |
|
| 01/18/2023 |
4
| Howarth Alex G. (CFO) has filed a Form 4 on MADRIGAL PHARMACEUTICALS, INC.|
Txns:
| Granted 15,001 shares
@ $0 |
|
| 01/18/2023 |
4
| FRIEDMAN PAUL A (CEO) has filed a Form 4 on MADRIGAL PHARMACEUTICALS, INC.|
Txns:
| Granted 26,668 shares
@ $0 |
|
| 01/18/2023 |
4
| Taub Rebecca (Pres., R&D, and CMO) has filed a Form 4 on MADRIGAL PHARMACEUTICALS, INC.|
Txns:
| Granted 20,001 shares
@ $0 |
|
| 01/06/2023 |
4
| Lynch Brian Joseph (SVP and General Counsel) has filed a Form 4 on MADRIGAL PHARMACEUTICALS, INC.|
Txns:
| Sold 600 shares
@ $277.91, valued at
$166.7k
Sold 400 shares
@ $279.1, valued at
$111.6k
Sold 1,800 shares
@ $280.66, valued at
$505.2k
Sold 2,656 shares
@ $281.97, valued at
$748.9k
Sold 2,628 shares
@ $282.97, valued at
$743.6k
Sold 1,549 shares
@ $283.85, valued at
$439.7k
Sold 829 shares
@ $285.15, valued at
$236.4k
Sold 2,038 shares
@ $285.74, valued at
$582.3k
Sold 400 shares
@ $286.62, valued at
$114.6k
Sold 100 shares
@ $287.86, valued at
$28.8k
Exercised 13,000 options to buy
@ $91.79, valued at
$1.2M
|
|
| 12/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/12/2022 |
4
| Lynch Brian Joseph (SVP and General Counsel) has filed a Form 4 on MADRIGAL PHARMACEUTICALS, INC.|
Txns:
| Granted 25,000 options to buy
@ $73.75, valued at
$1.8M
|
|
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2022 |
4
| MILLIGAN DAVID V (Director) has filed a Form 4 on MADRIGAL PHARMACEUTICALS, INC.|
Txns:
| Granted 9,470 options to buy
@ $65.06, valued at
$616.1k
|
|
| 06/21/2022 |
4
| CRAVES FRED B (Director) has filed a Form 4 on MADRIGAL PHARMACEUTICALS, INC.|
Txns:
| Granted 9,470 options to buy
@ $65.06, valued at
$616.1k
|
|
| 06/21/2022 |
4
| Levy Richard S (Director) has filed a Form 4 on MADRIGAL PHARMACEUTICALS, INC.|
Txns:
| Granted 9,470 options to buy
@ $65.06, valued at
$616.1k
|
|
| 06/21/2022 |
4
| Daly James M (Director) has filed a Form 4 on MADRIGAL PHARMACEUTICALS, INC.|
Txns:
| Granted 9,470 options to buy
@ $65.06, valued at
$616.1k
|
|
| 06/21/2022 |
4
| Gollust Keith R (Director) has filed a Form 4 on MADRIGAL PHARMACEUTICALS, INC.|
Txns:
| Granted 9,470 options to buy
@ $65.06, valued at
$616.1k
|
|
| 02/24/2022 |
4
| Howarth Alex G. (CFO) has filed a Form 4 on MADRIGAL PHARMACEUTICALS, INC.|
Txns:
| Granted 45,000 options to buy
@ $87.09, valued at
$3.9M
|
|
| 02/24/2022 |
4
| Lynch Brian Joseph (SVP and General Councel) has filed a Form 4 on MADRIGAL PHARMACEUTICALS, INC.|
Txns:
| Granted 45,000 options to buy
@ $87.09, valued at
$3.9M
|
|
| 02/24/2022 |
4
| Sukhija Remy (Chief Commercial Officer) has filed a Form 4 on MADRIGAL PHARMACEUTICALS, INC.|
Txns:
| Granted 45,000 options to buy
@ $87.09, valued at
$3.9M
|
|
| 02/24/2022 |
4
| Waltermire Robert E. (Senior VP, Chief Pharma Dev.) has filed a Form 4 on MADRIGAL PHARMACEUTICALS, INC.|
Txns:
| Granted 12,250 options to buy
@ $87.09, valued at
$1.1M
|
|
| 02/24/2022 |
4
| Taub Rebecca (See Remarks) has filed a Form 4 on MADRIGAL PHARMACEUTICALS, INC.|
Txns:
| Granted 61,500 options to buy
@ $87.09, valued at
$5.4M
|
|
| 02/24/2022 |
4
| FRIEDMAN PAUL A (CEO) has filed a Form 4 on MADRIGAL PHARMACEUTICALS, INC.|
Txns:
| Granted 70,000 options to buy
@ $87.09, valued at
$6.1M
|
|
| 12/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/07/2021 |
4
| CRAVES FRED B (10% Owner) has filed a Form 4 on MADRIGAL PHARMACEUTICALS, INC.|
Txns:
| Disposed of 750,270 shares
@ $0
Acquired 49,730 shares
@ $0
Disposed of 24,172 shares
@ $0 |
|
| 11/03/2021 |
4
| Howarth Alex G. (CFO) has filed a Form 4 on MADRIGAL PHARMACEUTICALS, INC.|
Txns:
| Granted 5,000 options to buy
@ $81.95, valued at
$409.8k
|
|
| 08/04/2021 |
4
| Waltermire Robert E. (Senior VP, Chief Pharma Dev.) has filed a Form 4 on MADRIGAL PHARMACEUTICALS, INC.|
Txns:
| Granted 35,000 options to buy
@ $87.92, valued at
$3.1M
|
|
| 06/21/2021 |
4
| Daly James M (Director) has filed a Form 4 on MADRIGAL PHARMACEUTICALS, INC.|
Txns:
| Granted 12,489 options to buy
@ $105.08, valued at
$1.3M
|
|
| 06/21/2021 |
4
| CRAVES FRED B (Director) has filed a Form 4 on MADRIGAL PHARMACEUTICALS, INC.|
Txns:
| Granted 12,489 options to buy
@ $105.08, valued at
$1.3M
|
|
| 06/21/2021 |
4
| MILLIGAN DAVID V (Director) has filed a Form 4 on MADRIGAL PHARMACEUTICALS, INC.|
Txns:
| Granted 12,489 options to buy
@ $105.08, valued at
$1.3M
|
|
| 06/21/2021 |
4
| BATE KENNETH (Director) has filed a Form 4 on MADRIGAL PHARMACEUTICALS, INC.|
Txns:
| Granted 12,489 options to buy
@ $105.08, valued at
$1.3M
|
|
| 06/21/2021 |
4
| Levy Richard S (Director) has filed a Form 4 on MADRIGAL PHARMACEUTICALS, INC.|
Txns:
| Granted 12,489 options to buy
@ $105.08, valued at
$1.3M
|
|
|
|
|